Luther King Capital Management (LKCM)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66M | Buy |
|
|||||
|
2025
Q1 | $68.4M | Buy |
|
|||||
|
2024
Q4 | $67.3M | Buy |
|
|||||
|
2024
Q3 | $72.4M | Buy |
|
|||||
|
2024
Q2 | $66M | Buy |
|
|||||
|
2024
Q1 | $59.6M | Buy |
|
|||||
|
2023
Q4 | $57.9M | Buy |
|
|||||
|
2023
Q3 | $66.3M | Sell |
|
|||||
|
2023
Q2 | $76.2M | Sell |
|
|||||
|
2023
Q1 | $89.1M | Sell |
|
|||||
|
2022
Q4 | $117M | Sell |
|
|||||
|
2022
Q3 | $99.8M | Sell |
|
|||||
|
2022
Q2 | $120M | Sell |
|
|||||
|
2022
Q1 | $119M | Buy |
|
|||||
|
2021
Q4 | $135M | Buy |
|
|||||
|
2021
Q3 | $97.1M | Sell |
|
|||||
|
2021
Q2 | $93.6M | Sell |
|
|||||
|
2021
Q1 | $88.6M | Sell |
|
|||||
|
2020
Q4 | $92.3M | Sell |
|
|||||
|
2020
Q3 | $94.3M | Buy |
|
|||||
|
2020
Q2 | $83.4M | Sell |
|
|||||
|
2020
Q1 | $97.5M | Buy |
|
|||||
|
2019
Q4 | $114M | Sell |
|
|||||
|
2019
Q3 | $104M | Buy |
|
|||||
|
2019
Q2 | $126M | Sell |
|
|||||
|
2019
Q1 | $124M | Sell |
|
|||||
|
2018
Q4 | $129M | Sell |
|
|||||
|
2018
Q3 | $131M | Sell |
|
|||||
|
2018
Q2 | $111M | Sell |
|
|||||
|
2018
Q1 | $114M | Sell |
|
|||||
|
2017
Q4 | $117M | Buy |
|
|||||
|
2017
Q3 | $99.5M | Sell |
|
|||||
|
2017
Q2 | $95.9M | Sell |
|
|||||
|
2017
Q1 | $99.6M | Sell |
|
|||||
|
2016
Q4 | $97.6M | Buy |
|
|||||
|
2016
Q3 | $101M | Buy |
|
|||||
|
2016
Q2 | $105M | Sell |
|
|||||
|
2016
Q1 | $88.6M | Sell |
|
|||||
|
2015
Q4 | $96.7M | Sell |
|
|||||
|
2015
Q3 | $95.9M | Buy |
|
|||||
|
2015
Q2 | $101M | Sell |
|
|||||
|
2015
Q1 | $112M | Buy |
|
|||||
|
2014
Q4 | $98.6M | Sell |
|
|||||
|
2014
Q3 | $93.8M | Sell |
|
|||||
|
2014
Q2 | $96.6M | Buy |
|
|||||
|
2014
Q1 | $102M | Buy |
|
|||||
|
2013
Q4 | $96.5M | Sell |
|
|||||
|
2013
Q3 | $90.9M | Buy |
|
|||||
|
2013
Q2 | $87M | Buy |
|